Opexa Therapeutics, Inc. (OPXA) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Research and development: 2.17M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 2.17M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $307.7 thousand versus the consensus estimate of $330 thousand.
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- Aon names interim CFO as Edmund Reese exits the firm
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
